Clinical trial

MR-based Hypofractionated Adaptive IGRT of Prostate Cancer (M-base HyPro 2.0)

NCT03880851

StatusUNKNOWN
Study typeINTERVENTIONAL
Start date2019-01-23
PhaseNA

Study timeline

Study start (actual)2019-01-23Date precision: day
Registry last updated2019-03-20
Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.